At its meeting held on January 21, the Eurasian Economic Commission's Council approved an amended version of the Requirements to Patient Information Leaflet and Summary of Product Characteristics.
According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.